View of Longitudinal Monitoring of Apparent Diffusion Coefficient (ADC) In Patients with Prostate Cancer Undergoing MR-guided Radiotherapy on an MR-Linac at 1.5 T: A Prospective Feasibility Study

Return to Article Details Longitudinal Monitoring of Apparent Diffusion Coefficient (ADC) In Patients with Prostate Cancer Undergoing MR-guided Radiotherapy on an MR-Linac at 1.5 T: A Prospective Feasibility Study Download Download PDF